Evidence map›Paper›PMID 34179027›Full record

ArticleBiomedicine hub

Infection Rate and Outcomes of Watchman Devices: Results from a Single-Center 14-Year Experience.

Robert C Ward, Trevon McGill, Fadi Adel, Shiva Ponamgi, Samuel J Asirvatham, Larry M Baddour, David R Holmes, Daniel C DeSimone, Christopher V DeSimone

Abstract read
In one paragraph

Article in Biomedicine hub. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Infective endocarditis associated with left atrial appendage occlusion device: a contemporary systematic review.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Robert C WardDepartment of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Trevon McGillDepartment of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Fadi AdelDepartment of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Shiva PonamgiDivision of Cardiology, Creighton University, Omaha, Nebraska, USA.
Samuel J AsirvathamDepartment of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Larry M BaddourDepartment of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
David R HolmesDepartment of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Daniel C DeSimoneDepartment of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Christopher V DeSimoneDepartment of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Watchman device (WD) is a commonly used alternative strategy to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation who have an increased bleeding risk. There are rare case reports of WD-related infection. Currently, there is no formal study that has systematically evaluated the incidence and outcomes WD-related infections. The objective of this study was to evaluate the incidence, risk factors, and outcomes for WD-associated infections in a single-center cohort over a 14-year period. All patients who underwent WD implantation over a 14-year study period (July 2004 through December 2018) comprised our cohort. Baseline characteristics, procedural data, and postimplantation events were identified through a retrospective chart review. Primary study outcomes included WD-related infection, other cardiovascular device-related infection, bacteremia, and mortality. A total of 181 patients (119 males; 65.7%) with a mean age of 75 years at implantation were included in the analysis. A total of 534.7 patient years of follow-up was accrued, with an average of 2.9 years per patient. The most common indications for implantation included gastrointestinal bleeding (56 patients; 30.9%) and intracerebral bleeding (51 patients; 28.2%). During the follow-up period, 37 (20.4%) patients died. Six developed evidence of bacteremia. Only 1 developed an implantable cardioverter defibrillator infection that required a complete system extraction. None of the cohort developed a WD-related device infection during the study period. We concluded that there is a low risk of WD-related infection even in the setting of a blood stream infection.

Indexed as

BacteremiaEndocarditisWatchman device

Identifiers

PMID34179027
PMCPMC8215937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.